1. Introduction {#sec1-1}
===============

Apart from psychotic symptoms, schizophrenia patients often experience increased risk of diabetes, hypertension, cardiovascular disease and even mortality due to adverse drug reactions, poor lifestyles or lack of exercise, which will further contribute to worse recovery prognosis and shorter life expectancies^\[[@ref1]\]^. A large number of recent studies indicated that aerobic exercise can significant improve psychiatric symptoms and increase quality of life^\[[@ref1]\]^.

Tai Chi as a form of moderate aerobic exercise originating in China, could promote balance and healing of the mind-body^\[[@ref4]\]^. Furthermore, Tai Chi comprises mental concentration, physical balance, relaxed breathing, and muscle relaxation, which shows great benefits in the rehabilitation of many medical and psychological conditions^\[[@ref9]\]^, including depression^\[[@ref6],[@ref8],[@ref9],[@ref12]\]^, rheumatoid arthritis^\[[@ref7]\]^, Parkinson's disease^\[[@ref13]\]^, cancer^\[[@ref16]\]^,chronic obstructive pulmonary disease ^\[[@ref19],[@ref20]\]^, type 2 diabetes ^\[[@ref21]\]^, and osteoarthritis ^\[[@ref22]\]^.

However, there is lack of evidence from systematic review or meta-analysis supporting the effects of Tai Chi on schizophrenia although it has been commonly used as adjunctive intervention to treat this disorder in Chinese societies^\[[@ref23]\]^. Thus, we conducted a systematic review and meta-analysis including the recent Tai Chi randomized controlled trials (RCTs) for patients with schizophrenia from both English and Chinese database, the latter being not widely known to the international readership to assess the efficacy of Tai Chi as an intervention treatment.

2. Methods {#sec1-2}
==========

2.1 Types of studies {#sec2-1}
--------------------

Any RCTs reporting the outcomes of the effects of Tai Chi for schizophrenia patients were includedin this review. We excluded case series, non-randomized studies, animal trials, and literature reviews.

2.2 Types of participants {#sec2-2}
-------------------------

Patients with a clinical diagnosis of schizophrenia, who met any diagnostic criteria (i.e. Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV)^\[[@ref26]\]^, International Classification of Diseases, 10th edition (ICD-10)^\[[@ref27]\]^, and Chinese Classification of Mental Disorders, third edition (CCMD-3)^\[[@ref28]\]^ were included.

2.3 Types of interventions {#sec2-3}
--------------------------

Interventions were limited to Tai Chi excluding other psychological interventions such as yoga, meditation, and mixed interventions (e.g., Tai Chi with music therapy or Tai Chi with acupuncture), and comparisons with any treatment (e.g. yoga, waitlist, and usual daily activities, et al) were included.

2.4 Types of Outcome measures {#sec2-4}
-----------------------------

The primary outcome psychopathology measure was both positive and negative symptoms assessed by the positive and negative syndrome scale (PANSS)^\[[@ref29]\]^, Scale for the assessment of negative (SANS)^\[[@ref30]\]^, or Scale for the Assessment of Positive Symptoms (SAPS)^\[[@ref31]\]^, respectively. Key secondary outcome were social function, abnormal behaviors, cognitive function, perceived stress, adverse events and discontinuation rate. Furthermore, we recorded clinical outcomes based on intent to treat (ITT) analysis if available.

2.5 Data Searches {#sec2-5}
-----------------

PubMed, PsycINFO, Embase, Cochrane Library databases, the Cochrane Controlled Trials Register and Chinese databases (WanFang Database, Chinese Biomedical database and China Journal Net) were searched, from inception of the database until Aug 27 2016, using the following search terms: (Schizophrenia OR Schizophrenias OR Schizophrenic Disorder OR Disorder, Schizophrenic OR Disorders, Schizophrenic OR Schizophrenic Disorder OR Dementia Praecox) AND (Tai-ji OR Tai Chi OR Chi, Tai OR Tai Ji Quan OR Ji Quan, Tai OR Quan, Tai Ji OR Taiji OR Taijiquan OR T'ai Chi OR Tai Chi Chuan) AND (randomized controlled trial OR controlled clinical trial OR randomized OR placebo OR randomly OR trial OR groups).

We also hand-searched reference lists from identified and relevant review articles for additional studies, and contacted authors for unpublished data.

2.6 Data extraction {#sec2-6}
-------------------

Two of the authors (WZ and TG) independently conducted the original research, study selection, data extraction, quality assessment, and data synthesis. Any inconsistencies were resolved by discussion. Data were extracted into simple, standardized forms. Furthermore, authors were contacted to obtain missing information or clarification.

2.7 Statistical methods {#sec2-7}
-----------------------

The statistical analyses were performed using Review Manager (version 5.3) in this meta-analysis according to the recommendations of the Cochrane Collaboration. To minimize the effect of chance, we only meta-analyzed outcomes for which data were available in at least three studies. For continuous data, the effect size (ES) was determined by calculating weighted mean difference (WMD) or standard mean difference (SMD) with 95% confidence interval (CI) according to outcome measurements; for dichotomous data risk ratio (RR)with 95% CI was computed. We assessed the *Q*-test and *I*^2^ to quantify heterogeneity: if *p*\>0.10 or *I*^2^\<50, it indicates that the study results were homogeneous^\[[@ref32]\]^ and a fixed effect model was employed to meta-analyze the pooled sample; otherwise a random effects model was employed^\[[@ref33]\]^. Furthermore, one RCT^\[[@ref5]\]^ with three study arms was included in the meta-analysis. In order to include each of the 2 adjunctive Tai Chi arms separately, we included the Tai Chi treatment arm twice in the analysis, but assigned half of the patient group to each arm in order to not inflate the total number of patients. Publication bias was assessed using funnel plots and Egger's test^\[[@ref34]\]^. All analyses were 2 tailed, with alpha set at 0.05.

2.8 Risk of bias assessment {#sec2-8}
---------------------------

The Cochrane Risk of Bias including the methods of random sequence generation (selection bias), allocation concealment (selection bias), blinding of participants and personnel (performance bias), blinding of outcome assessment (detection bias), incomplete outcome data (attrition bias), selective reporting (reporting bias), and other biases was used to assess the methodological quality of RCTs ^\[39\]^.

2.9 Clinical evidence recommendation {#sec2-9}
------------------------------------

The quality of evidence and strength of recommendations of outcome measure of Tai Chi for schizophrenia was assessed using the grading of recommendations assessment, development, and evaluation (GRADE) system as 'very low', 'low', 'moderate', or 'high'^\[40\]^.

3. Results {#sec1-3}
==========

3.1 Results of the search {#sec2-10}
-------------------------

[Figure 1](#fig001){ref-type="fig"} shows that 6 RCTs (n=483)^\[[@ref4],[@ref5],[@ref23]\]^ from Chinese (4trials)^\[[@ref23]\]^and English databases (2 trials)^\[[@ref4],[@ref5]\]^ were included in this meta-analysis after removing duplicate articles (n=17), reviewing the titles or abstracts (n=29) and full texts (n=3) from originally relevant articles (n=55).

3.2 The characteristics of included studies {#sec2-11}
-------------------------------------------

[Table 1](#table001){ref-type="table"} summarizes6 RCTs^\[[@ref4],[@ref5],[@ref23]\]^conducted in Chinese societies. A total of 483 participants (range: 30-153, median 70) including 215 subjects in the intervention group and 268 subjects in the control group lasted 16.0 (6.2) (range: 12-24, median 12) weeks. The participants with available data were 41.3 (10.4) (range 18-65, median 38.9) years old, 64.0 (20.5)% (range 40%-100%, median 59.5%) was males, and the mean illness duration was 13.8 (12.1) (range=2.6-29.9, median=9.7) years.

Five RCTs^\[[@ref4],[@ref23]\]^ implemented two arms and one^\[[@ref5]\]^ implemented a three-arm design in which a second comparison group were introduced. Furthermore, style of tai chi included 24-style (3 trials)^\[[@ref23]\]^, Wustyle (2 trials)^\[[@ref4],[@ref5]\]^ and Sun-style (1 trial)^\[[@ref4],[@ref5]\]^, while the control group received treatment including routine care (1 trial)^\[[@ref24]\]^, no exercise (2 trials)^\[[@ref23]\]^, health education (1 trial)^\[[@ref25]\]^, waitlist (2 trials)^\[[@ref4],[@ref5]\]^, and exercise program (trial=1)^\[[@ref5]\]^.

3.3 Assessment of risk of bias and quality assessment {#sec2-12}
-----------------------------------------------------

[Table 2](#table002){ref-type="table"} describes that while 2 RCTs^\[[@ref4],[@ref23]\]^ mentioned "random" assignment with specific description; most studies were rated as unclear risk (n=2)^\[[@ref5],[@ref13]\]^ and high risk (n=2)^\[[@ref24],[@ref25]\]^. Furthermore, the allocation of concealment methods, masked assessors and blinding of the assessments were rated as high risk in all RCTs. Loss to follow-up was described by three RCTs^\[[@ref4],\ [@ref5],\ [@ref11]\]^, which used ITT analysis for incomplete outcome. Furthermore, selective reporting and other bias were rated as high risk and unclear risk in all RCTs, respectively. Furthermore, as only 5 RCTs^\[[@ref4],[@ref5],[@ref23]\]^ with 6 treatment arms provided meta-analyzable data, we could not conduct a funnel plot analysis to show the presence of risk of publication bias^\[41\]^.

3.4 Meta-analysis results {#sec2-13}
-------------------------

### 3.4.1 Primary outcomes {#sec3-1}

While there were significant differences between the two groups in the changed total scores of the PANSS (2 trials) (Ho 2016 and Gan 2007), SANS (4 trials) (Xie 2008, Zhou 2011, Ho 2012 and Chen 2013) and SAPS (1 trial) (Chen 2013) over the study period, only 5 RCTs^\[[@ref4],[@ref5],[@ref23]\]^ with 6 treatment arms provided meta-analyzable data. Compared to control group, we found significantly differences on improvement of negative symptoms (5 trials with 6 treatment arms, n=451, SMD:-0.87 (95% CI: -1.51, -0.24), *p*=0.007; *I*^2^=90%, [Figure 2](#fig002){ref-type="fig"}) in the intervention group. Regarding improvement of positive symptoms (4 trials with 5 treatment arms, n=391, SMD:-0.09 (95% CI: -0.44, 0.26), *p*=0.60; *I*^2^=65%, [Figure 3](#fig003){ref-type="fig"}), we did not find significant differences between the two groups.

As shown in [Table 3](#table003){ref-type="table"}, based on the GRADE measure, the strength of the evidence supporting the adjunctive effect of Tai Chi on negative and positive symptoms in schizophrenia was classified as 'very low', while discontinuation rate of adjunctive Tai Chi for schizophrenia was classified as "moderate".

### 3.4.2 Secondary outcomes {#sec3-2}

In the 5 RCTs with meta-analyzable data, social function(3 trials) (Ho 2016, Gan 2007 and Xie 2008), abnormal behaviors(1 trial) (Gan 2007), cognitive function (2 trials)(Ho 2016 and Chen 2013) and perceived stress(1 trial)(Ho 2016) were assessed as secondary outcomes ([Table 1](#table001){ref-type="table"}). Regarding social function as measured by Inpatient Psychiatric Rehabilitation Outcome Scale (IPROS)^\[[@ref24]\]^, Social Disability Screening Schedule (SDSS)^\[[@ref23]\]^ and Treatment Rehabilitation Scale (TRS)^\[[@ref12]\]^, there was significant improvement in the intervention group. No significant difference was found between the Tai Chi group and the control group in social function as measured by Lawton's Instrumental Activities of Daily Living (IADL)^\[[@ref23]\]^ and Activities of Daily Living (ADL)^\[[@ref23]\]^. In Gan et al's study^\[[@ref23]\]^, there was greater improvement in abnormal behaviors as measured by the Nurse's Observation Scale for Inpatient Evaluation (NOSIE)in the intervention group than the controls. Regarding cognitive function and perceived stress as measured by the Neurological Evaluation Scale (NES)^\[[@ref23]\]^, backward digit spans of Wechsler Adult Intelligence Scale, Third Edition -- Chinese version (WAIS-III)^\[[@ref23]\]^, Backward Masking Test (BMT) ^\[[@ref13]\]^ and Continuous Performance Test (CPT)^\[[@ref13]\]^, there was significant improvement in the intervention group. However, there was no significant difference regarding cognitive function assessed the forward digit spans of WAIS-III^\[[@ref23]\]^ and perceived stress as measured by the Perceived Stress Scale (PSS) ^\[[@ref5]\]^ respectively.

Furthermore, there was no significant difference regarding discontinuation rate between the Tai Chi treatment and the control groups (3 trials with 4 treatment arms, n=334, RR: 0.57 (95% CI: 0.23, 1.40), *p*=0.22; I^2^=0%, [Figure 4](#fig004){ref-type="fig"}). All included RCTs did not report side effects of Tai Chi.

3.5 Studies not in the meta-analysis {#sec2-14}
------------------------------------

One study^\[[@ref4],[@ref5]\]^ were not included in the meta-analysis and found that Tai-Chi could effectively prevented deterioration in movement coordination, interpersonal functioning and disruptions to life activities compared to the control group.

4. Discussion {#sec1-4}
=============

4.1 Main findings {#sec2-15}
-----------------

This systematic review and meta-analysis summarizes results of the effects of Tai Chi exercise on different outcomes in schizophrenia. Evidence from 6 RCTs (n=483) indicated that, Tai Chi as an adjunctive intervention for schizophrenia, appears to have beneficial effects on patients. Specifically, the 5 meta-analyzable RCTs reported that 12-24 weeks of regular Tai Chi activity significantly improved negative symptoms, but had no obvious effects on positive symptoms compared to the controls. In addition, Tai Chi had may improve social function, abnormal behaviors and cognitive function. In contrast, the non-meta-analyzable studies suggested that patients may benefit from Tai Chi in preventing deterioration in movement coordination and interpersonal functioning.

Our results are broadly consistent with recent individual studies and reviews supporting the notion that aerobic exercise can significantly improve psychiatric symptoms^\[[@ref1]\]^. A recent systematic review^\[[@ref35]\]^ reported that qigong, another mind body exercise similar to Tai Chi, could be beneficial for improving depressive symptoms. Another meta-analysis of both Chinese and English language publications^\[[@ref8]\]^ found that Tai Chi was associated with improvements in stress, anxiety, depression and self-esteem.

4.2 Limitation {#sec2-16}
--------------

First, the sample size was relatively small in the 6 RCTs (30 to 153 cases)with limited or incomplete information. Moreover, given the small number of included studies (6 trials), publication bias could not be assessed. This also limited our capability to conduct a more comprehensive data exploration of effect size moderators (i.e. subgroup analysis, sensitivity analysis, and meaningful meta-regression analyses) for improvement of negative symptoms. Second, the 4 RCTs had short treatment duration and hence the effects of Tai Chi's beyond 24 weeks require further study. Thirdly, prior reviews and meta-analyses indicated Tai Chi has the potential to improving quality of life in other populations^[@ref10]^, therefore such effects for schizophrenia patients need to be further evaluated. Finally, no study provided data on side effects and the quality of this evidence using GRADE was only classified as 'very low' (67%) and 'moderate' (33%). Thus, high quality studies are needed to confirm and expand on the currently available evidence.

4.3 Implication {#sec2-17}
---------------

Similar to prior meta-analysis^\[[@ref8]\]^, there is insufficient evidence to determine type- and dose-response effects of Tai Chi on schizophrenia. The studies to date showed a wide variety of types, frequency and duration of Tai Chi. For example, the 24-style was used in three studies, and Wu-style was used in another two. The frequency of Tai Chi exercise varied between 1 and 7 per week, while the duration ranged between 30-60 minutes per session. Furthermore, only short-term effects of Tai Chi were examined in completed studies (12-24 weeks) although the treatment adherence with available data was satisfactory (80-100%). In future studies the intensity, frequency, duration of Tai Chi exercise should be standardized and the dose-response effects need to be further examined.

In traditional Chinese medicine, Tai Chi, which encompasses breathing (Chi) and physical movements, can create physical, emotional and spiritual balance, while enhancing self-fulfillment and self-realization^\[[@ref36]\]^. To date, however, the underlying mechanism of action of Tai Chi's effects on psychiatric disorders including schizophrenia has not been identified. The possible mechanisms of Tai Chi exercise for enhanced psychiatric symptoms and related outcomes may result from its beneficial influence on physiological, neurological, cardiovascular and immunological effects and overall well-being^\[[@ref8]\]^. In addition, it should be noted that all included studies were conducted in Chinese treatment settings where cultural beliefs may lead to an expectancy of benefits from Tai Chi. Therefore effects of Tai Chi on schizophrenia need to be replicated in non-Chinese settings in the future.

This is the first meta-analysis of Tai Chi as an adjunctive treatment for patients with schizophrenia. Most previous meta-analyses and reviews have focused on the effect of Tai Chi on psychological well-being in major depressive disorder^\[[@ref6],[@ref8],[@ref9],[@ref12]\]^. Tai chi is an inexpensive and safe mind-body practice and may enhance the general well-being of schizophrenia patients, therefore could be integrated into the complex management of schizophrenia. The major strength of this study is that the meta-analysis was based on recent, methodically rigorous RCTs published in both English and Chinese languages. This meta-analysis gave the international readership access to studies on Tai Chi published in Chinese journals, which are rarely available. Tai Chi is popular and widely practiced now in the general population all over the world therefore finding qualified Tai Chi practitioners to employ by mental health services would not be difficult.
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###### 

Studies and Patients Characteristics

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study                           N     Design:\                                     Trial\      Country   Participants:\                    Ageb:\         Sex:\         Interventions:\                                                    Intervention frequency (Tai Chi)          Outcomes     Treatment adherence (Tai Chi, %)   Dropout rate (Tai Chi, %)   
                                        -Blinding\                                   Duration\             -Diagnosis\                       years\         Male\         Number of patients                                                                                                                                                                       
                                        -Setting                                     (weeks)               -Criteria\                        (range)        (%)                                                                                                                                                                                                    
                                                                                                           -Illness duration (year)                                                                                                                                                                                                                                
  ------------------------------- ----- -------------------------------------------- ----------- --------- --------------------------------- -------------- ------------- ------------------------------------------------------------------ ----------------------------------------- ------------ ---------------------------------- --------------------------- --
  Xie et al 2008^11^              100   \                                            12          China     -Sz\                              35.6 (18-60)   n=60 (60%)    1\. APs + TC + routine care; n=50\                                 45 min, 3×/wk (24 style)                  IPROS;\      98                                 2                           
                                        -Open label\                                                       -CCMD-3 -Illness duration: 10.3                                2. APs + routine care; n=50                                                                                  SANS;\                                                                      
                                        -Inpatients                                                                                                                                                                                                                                    SAPS                                                                        

  Gan et al 2007^\[[@ref10]\]^    80    -Open label\                                 12          China     -Sz\                              27.2 (19-55)   n=47 (59%)    1\. APs + TC; n=39\                                                60min,\                                   PANSS;\      100                                0                           
                                        -Inpatients                                                        -CCMD-3\                                                       2. APs + without any kind of exercise; n=41                        5×/wk\                                    NOSIE;\                                                                     
                                                                                                           -Illness duration: 2.6                                                                                                            (24 style)                                SDSS                                                                        

  Zhou et al 2011^\[[@ref12]\]^   60    -Open label -Inpatients                      12          China     -Sz\                              40.2 (21-62)   n=43 (72%)    1\. APs + TC; n=30\                                                60min, 7×/wk (24 styl)                    SANS;\       100                                0                           
                                                                                                           -CCMD-3\                                                       2. APs + health education; n=30                                                                              TRS                                                                         
                                                                                                           -Illness duration:\                                                                                                                                                                                                                                     
                                                                                                           2.8                                                                                                                                                                                                                                                     

  Ho et al 2012^\[[@ref4]\]^      30    -Open label\                                 12          China     -Sz\                              53.0 (18-65)   n=12 (40%)    1\. APs + TC; n=15\                                                60min, 2×/wk+30 min, l×/wk (Wu-style)     CMDT;\       NR                                 20                          
                                        -Others[^a^](#tfn001){ref-type="table-fn"}                         DSM-IV\                                                        2. APs + waitlist; n=15                                                                                      SNS;\                                                                       
                                                                                                           -Illness duration 27.8                                                                                                                                                      W H 0\                                                                      
                                                                                                                                                                                                                                                                                       - DAS-II                                                                    

  Chen et al 2013^\[[@ref13]\]^   60    -Open label\                                 24          China     -Sz\                              37.6 (26-60)   n=60 (100%)   1\. APs + TC; n=30 2. APs + + without any kind of exercise; n=30   60min, 7×/wk (Sun-style)                  SANS;\       100                                0                           
                                        -Inpatients                                                        -CCMD-3\                                                                                                                                                                    SAPS;\                                                                      
                                                                                                           -Illness duration 9.1                                                                                                                                                       BMT;\                                                                       
                                                                                                                                                                                                                                                                                       CPT                                                                         

  Ho et al 2016^\[[@ref5]\]^      153   -Open label\                                 24          China     -Sz\                              54.0 (18-65)   n=80 (53%)    1\. APs + TC; n=53. APs + exercise program; n=51                   60min, 1 × / wk+45min, 2x/wk (Wu-style)   PANSS;\      NR                                 2                           
                                        -Others[^a^](#tfn001){ref-type="table-fn"}                         -DSM-IV\                                                                                                                                                                    NES;\                                                                       
                                                                                                           -Illness duration 29.9                                                                                                                                                      AD- L;\                                                                     
                                                                                                                                                                                                                                                                                       WAIS-III;\                                                                  
                                                                                                                                                                                                                                                                                       IADL;\                                                                      
                                                                                                                                                                                                                                                                                       PSS                                                                         
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^patients come from both long-stay care and halfway house services;

^b^weighted mean; APs = antipsychotics; ADL = Activities of Daily Living; BMT=Backward Masking Test; CMDT = Movement Coordination Tests; CCMD-3 = Chinese Classification of Mental Disorders, third edition; CPT = continuous performance test; DSM-IV = Diagnostic and Statistical Manual of Mental Disorders 4th edition; IPROS = Inpatient Psychiatric Rehabilitation Outcome Scale; IADL = Lawton's Instrumental Activities of Daily Living; NR = not reported; NOSIE = Nurse's Observation Scale for Inpatient Evaluation; NES = Neurological Evaluation Scale; PSS = Perceived Stress Scale; PANSS = Positive and Negative Syndrome Scale; SDSS = Social Disability Screening Schedule; R= range; SANS = Scale for the Assessment of Negative Symptoms; SAPS = Scale for the Assessment of Positive Symptoms; Sz = schizophrenia; TC = Tai Chi; TRS=Treatment Rehabilitation Scale; WHODAS-II = World Health Organization Disability Assessment Schedule; WAIS-III = Wechsler Adult Intelligence Scale, Third Edition--Chinese version.

###### 

Evaluation of risk of bias in the six included studies

  study                           sequence generation   allocation sequence oncealment   blinding of participants and personnel   blinding of outcome assessment   incomplete outcome data   selective outcome reporting   other potential threats to validity
  ------------------------------- --------------------- -------------------------------- ---------------------------------------- -------------------------------- ------------------------- ----------------------------- -------------------------------------
  Xie et al 2008^\[[@ref11]\]^    high                  high                             high                                     high                             low                       N/A                           low
  Gan et al 2007^\[[@ref10]\]^    low                   high                             high                                     high                             low                       N/A                           low
  Zhou et al 2011^\[[@ref12]\]^   high                  high                             high                                     high                             low                       N/A                           low
  Ho et al 2012^\[[@ref4]\]^      low                   high                             high                                     high                             low                       N/A                           low
  Chen et al 2013^\[[@ref13]\]^   N/A                   high                             high                                     high                             low                       N/A                           low
  Ho et al 2016^\[[@ref5]\]^      N/A                   high                             high                                     high                             low                       N/A                           low

N/A=no information available

###### 

GRADE Analyses: Tai Chi for Schizophrenia

  Design                   N (arms)   Risk of bias                                 Inconsistency                                Indirectness   Imprecision   Publication bas                              Large effect   Overall quality of evidence
  ------------------------ ---------- -------------------------------------------- -------------------------------------------- -------------- ------------- -------------------------------------------- -------------- -----------------------------
  Positive symptom score   391(5)     Serious[^b^](#tfn004){ref-type="table-fn"}   Serious[^c^](#tfn005){ref-type="table-fn"}   No             No            Serious[^d^](#tfn006){ref-type="table-fn"}   No             +/-/-/-/; Very Low
  Negative symptom score   451(6)     Serious[^b^](#tfn004){ref-type="table-fn"}   Serious[^c^](#tfn005){ref-type="table-fn"}   No             No            Serious[^d^](#tfn006){ref-type="table-fn"}   No             +/-/-/-/; Very Low
  Discontinuation rate     334(4)     Serious[^b^](#tfn004){ref-type="table-fn"}   No                                           No             No            No                                           No             +/+/+/-/; Moderate

GRADE = grading of recommendations assessment, development, and evaluation;

^a^GRADE Working Group grades of evidence: High quality=further research is very unlikely to change our confidence in the estimate of effect. Moderate quality=further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. Low quality=further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. Very low quality=we are very uncertain about the estimate.

^b^All studies reported as having a serious bias used aopen label method, only mentioned random allocation without describing the method and withdrawal from the study.

^c^All studies reported as having a serious inconsistency had *I^2^\>* 50%.

^d^For continuous outcomes, N \< 400

[^1]: ^\#^equal contribution to the paper.
